Cilostazol induced migraine does not respond to sumatriptan in a double blind trial.

J Headache Pain · 2018 · PMC5796931 · PMID 29396788

Europe PMC DOI

hedged sentences

0.0060

closest p · 0.1× alpha

0.0060

boldest claim

The sentences

highly significantp = 0.006actually significant

During spontaneous attacks, the difference between placebo and sumatriptan was not significant at 2 h ( p = 0.26), but it was highly significant at 4 h ( p = 0.006).

also in 132,142 other papers

showed a trendno p-value reported

At 2 h after treatment, sumatriptan showed a trend towards efficacy and 4 h after treatment the effect was highly significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.